We are live on ! Find out more
RLYB icon

Rallybio

45 hedge funds and large institutions have $14.1M invested in Rallybio in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more capital invested

Capital invested by funds: $10.5M → $14.1M (+$3.6M)

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

0.91% less ownership

Funds ownership: 9.37%8.46% (-0.91%)

6% less funds holding

Funds holding: 4845 (-3)

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

Holders
45
Holders Change
-3
Holders Change %
-6.25%
% of All Funds
0.59%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
6
Increased
7
Reduced
12
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
51
Jane Street
New York
-$3.97K -1,468 Closed
HSBC Holdings
52
HSBC Holdings
United Kingdom
-$3.5K -1,315 Closed
Federated Hermes
53
Federated Hermes
Pennsylvania
-$747 -276 Closed
Raymond James Financial
54
Raymond James Financial
Florida
-$288 -106 Closed

RLYB Hedge Fund Activity: Q3 2025 in Review

45 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q3 2025, worth a combined $14.1M — up 34% from $10.5M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of RLYB and 6 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 7 added.

The largest buyer was Citadel Advisors, adding an estimated $196K. The largest seller was Aberdeen Group, exiting entirely with an estimated $539K sold.

  • 45 institutional investors held Rallybio (RLYB) as of Q3 2025, down from 48 in Q2 2025.
  • Funds reported $14.1M of Rallybio stock for Q3 2025, up 34% quarter-over-quarter.
  • 6 funds opened new Rallybio positions in Q3 2025 and 9 closed out, a net change of -3 holders.
  • The largest Rallybio buyer in Q3 2025 was Citadel Advisors, an estimated $196K added.
  • The largest Rallybio seller in Q3 2025 was Aberdeen Group, an estimated $539K sold.

Based on aggregated 13F filings for Q3 2025.